I have 23 years of experience, and specialize in the field of hematology and oncology with specific knowledge in the areas of genitourinary, melanoma, sarcoma, gastrointestinal malignancies, breast cancer, lung cancer, leukemia and lymphomas. I have published on such topics as cancer cell biology, IL-2 treatment in renal cell carcinoma, a variety of cancer agents in clinical trials and preliminary data on a new serum marker for prostate cancer. I am a seasoned cancer clinician and clinical investigator. I have extensive training and expertise in the area of cancer drug development, clinical trials and requirements for FDA approval of anti-cancer agents. In fact, I have participated in or directed over 100 clinical trials in the area of cancer therapeutics.